Redefining Cholangiocarcinoma Management: Breakthroughs and Their Clinical Implications for Clinical Practice
Clinical Gastroenterology and Hepatology · 2026-10
DOI: 10.1016/j.cgh.2026.10.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-10. Verfasst von Sudha Kodali und 2 weiteren Autor:innen. Beteiligte Einrichtung: Sherrie and Alan Conover Center for Liver Disease and Transplantation, JC Walter Jr Transplant Center, Houston Methodist Hospital, Houston, Texas; De….
Abstract (Originalsprache)
Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies that originates in the biliary epithelium and is anatomically classified into intrahepatic (iCCA) and extrahepatic (eCCA) subtypes. These tumors often progress silently and are associated with a poor prognosis, limiting the opportunities for timely intervention. Most patients do not have identifiable risk factors. Recent improvements in imaging techniques and next-generation sequencing (NGS) have enhanced diagnostic accuracy and enabled identification of actionable molecular alterations (e.g., FGFR2 fusions, IDH1 mutations). These advances have supported biomarker-driven therapies and integration of immunotherapy into first-line treatment. However, persistent gaps in risk stratification and early detection remain major barriers to improving outcomes. This review highlights recent advancements in CCA treatment and management, emphasizing practical considerations for gastroenterologists and hepatologists.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sherrie and Alan Conover Center for Liver Disease and Transplantation, JC Walter Jr Transplant Center, Houston Methodist Hospital, Houston, Texas; Department of Medicine, Houston Methodist Hospital, Houston, Texas; Depa…
- Division of Digestive and Liver Disease, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.
- Sherrie and Alan Conover Center for Liver Disease and Transplantation, JC Walter Jr Transplant Center, Houston Methodist Hospital, Houston, Texas; Department of Surgery, Houston Methodist Hospital, Houston, Texas; Depar…
Zitieren
APA
Kodali, S., Rich, N. E., & Ghobrial, R. M. (2026). Redefining Cholangiocarcinoma Management: Breakthroughs and Their Clinical Implications for Clinical Practice. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.10.005
Vancouver
Kodali S, Rich NE, Ghobrial RM. Redefining Cholangiocarcinoma Management: Breakthroughs and Their Clinical Implications for Clinical Practice. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.10.005
BibTeX
@article{Kodali2026,
author = {Kodali, Sudha and Rich, Nicole E and Ghobrial, R Mark},
title = {Redefining Cholangiocarcinoma Management: Breakthroughs and Their Clinical Implications for Clinical Practice},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.10.005}
}
EUVIMED